Pharmacy Times August 21, 2024
Brandon Newman highlights the need for balanced regulation, transparency, and real-time data access to ensure fair competition and optimal outcomes for pharmacy benefit mangers.
Brandon Newman, the founder and CEO of Xevant, emphasizes the importance of balanced regulation and transparency in the pharmacy industry. He cautions that proposed legislation could stifle competition and innovation if not carefully crafted, potentially leading to big PBMs exiting certain contracts. Newman argues that simply setting prices through government mandates does not necessarily achieve the desired outcomes, as manufacturers may raise prices elsewhere to compensate. Instead, he advocates for incentivizing positive behaviors and providing stakeholders, including pharmacists and pharmacies, with real-time access to claims data, rebates, and cost-saving opportunities.
Q: With the push for more...
Today's Sponsors
Today's Sponsor